Cytidine Monophosphate N-Acetylneuraminic Acid Synthetase (CMAS) Peptide
Quick Overview for Cytidine Monophosphate N-Acetylneuraminic Acid Synthetase (CMAS) Peptide (ABIN938917)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- GRGVEKPPHL AALILARGGS KGIPLKNIKH LAGVPLIGWV LRAALDSGAF
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CMAS antibody,
Alternative Names: CMAS control peptide, CMAS antibody Blocking Peptide, Anti-CMAS Blocking Peptide, Cytidine Monophosphate N-Acetylneuraminic Acid Synthetase Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- CMAS (Cytidine Monophosphate N-Acetylneuraminic Acid Synthetase (CMAS))
-
Background
- CMAS is an enzyme that catalyzes the activation of Neu5Ac to Cytidine 5-prime-monophosphate N-acetylneuraminic acid (CMP-Neu5Ac), which provides the substrate required for the addition of sialic acid. Sialic acids of cell surface glycoproteins and glycolipids play a pivotal role in the structure and function of animal tissues. The pattern of cell surface sialylation is highly regulated during embryonic development, and changes with stages of differentiation. Studies of a similar murine protein suggest that this protein localizes to the nucleus.
-
Molecular Weight
- 48 kDa
Target
-